Education
About Us
Working with TipRanks
Follow Us
Establishment Labs Holdings Inc (ESTA)
NASDAQ:ESTA
ESTA Stock Chart & Stats
$49.59
-$0.07(-0.15%)
At close: 4:00 PM EST
$49.59
-$0.07(-0.15%)
Day’s Range― - ―
52-Week Range$26.56 - $50.85
Previous CloseN/A
Volume125.18K
Average Volume (3M)306.15K
Market Cap
$1.44B
Enterprise Value$1.41B
Total Cash (Recent Filing)$54.64M
Total Debt (Recent Filing)$224.50M
Price to Earnings (P/E)―
Beta1.23
Next Earnings
Nov 05, 2025EPS Estimate
-0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding28,970,736
10 Day Avg. Volume370,691
30 Day Avg. Volume306,149
Financial Highlights & Ratios
PEG Ratio6.73
Price to Book (P/B)24.44
Price to Sales (P/S)7.81
P/FCF Ratio-17.51
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue7.96
Enterprise Value/Gross Profit11.83
Enterprise Value/Ebitda-25.81
Forecast
1Y Price Target
$57.33Price Target Upside15.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevenue growth improved to 16% from 11%, and US sales grew approximately 70% sequentially, beating consensus.
Innovative TechnologyESTA's innovative portfolio featuring best-in-class data and leveraging multiple demand trends is poised to take considerable share in the US market as its domestic launch continues and as it submits more of its products/indications to the FDA.
Market ExpansionThe rollout of Preservé plays a key role in ESTA's minimally invasive strategy for the US market.
Revenue GrowthESTA confirmed the limited launch of Preservé in the US and announced expectations for its minimally invasive platform to generate at least $30M in revenue in 2026, with continued TAM expansion on both a dollar and procedure basis.
Bears Say
Profitability ChallengesAdjusted EBITDA margin decreased by 740 basis points year over year due to spending on the US launch.
Regional Sales DeclineSales declined year-over-year in AsiaPac largely due to the China distributor order comp.
Establishment Labs Holdings News
ESTA FAQ
What was Establishment Labs Holdings Inc’s price range in the past 12 months?
Establishment Labs Holdings Inc lowest stock price was $26.55 and its highest was $50.85 in the past 12 months.
What is Establishment Labs Holdings Inc’s market cap?
Establishment Labs Holdings Inc’s market cap is $1.44B.
When is Establishment Labs Holdings Inc’s upcoming earnings report date?
Establishment Labs Holdings Inc’s upcoming earnings report date is Nov 05, 2025 which is in 11 days.
How were Establishment Labs Holdings Inc’s earnings last quarter?
Establishment Labs Holdings Inc released its earnings results on Aug 07, 2025. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.532 by -$0.038.
Is Establishment Labs Holdings Inc overvalued?
According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued.
Does Establishment Labs Holdings Inc pay dividends?
Establishment Labs Holdings Inc does not currently pay dividends.
What is Establishment Labs Holdings Inc’s EPS estimate?
Establishment Labs Holdings Inc’s EPS estimate is -0.51.
How many shares outstanding does Establishment Labs Holdings Inc have?
Establishment Labs Holdings Inc has 28,970,736 shares outstanding.
What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?
Establishment Labs Holdings Inc reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.532. Following the earnings report the stock price went down -13.951%.
Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?
Currently, no hedge funds are holding shares in ESTA
Establishment Labs Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$57.33 (15.61% Upside)
$57.33 (15.61% Upside)
Hedge Fund Trend
Increased
By 650.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $277.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 12.8%
Last 30 Days ▲ 12.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.76%
12-Months-Change
Fundamentals
Return on Equity
-261.18%
Trailing 12-Months
Asset Growth
15.64%
Trailing 12-Months
Company Description
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
ESTA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with strong revenue growth and successful market penetration in the U.S. and Europe. However, challenges in the Chinese market and increased operating expenses present some concerns.View all ESTA earnings summariesESTA Stock 12 Month Forecast
Average Price Target
$57.33
▲(15.61% Upside)
Technical Analysis
Ownership Overview
20.02% Insiders
11.44% Mutual Funds
3.35% Other Institutional Investors
64.35% Public Companies and
Individual Investors